CN101258154B - 作为组胺h3拮抗剂的吡唑并[3,4-d]氮杂䓬衍生物 - Google Patents

作为组胺h3拮抗剂的吡唑并[3,4-d]氮杂䓬衍生物 Download PDF

Info

Publication number
CN101258154B
CN101258154B CN2006800322776A CN200680032277A CN101258154B CN 101258154 B CN101258154 B CN 101258154B CN 2006800322776 A CN2006800322776 A CN 2006800322776A CN 200680032277 A CN200680032277 A CN 200680032277A CN 101258154 B CN101258154 B CN 101258154B
Authority
CN
China
Prior art keywords
alkyl
azepine
phenyl
heteroaryl
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2006800322776A
Other languages
English (en)
Chinese (zh)
Other versions
CN101258154A (zh
Inventor
马克·J·班福德
戴维·M·威尔逊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of CN101258154A publication Critical patent/CN101258154A/zh
Application granted granted Critical
Publication of CN101258154B publication Critical patent/CN101258154B/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CN2006800322776A 2005-07-06 2006-07-04 作为组胺h3拮抗剂的吡唑并[3,4-d]氮杂䓬衍生物 Expired - Fee Related CN101258154B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0513886.2 2005-07-06
GBGB0513886.2A GB0513886D0 (en) 2005-07-06 2005-07-06 Novel compounds
PCT/EP2006/006613 WO2007025596A1 (en) 2005-07-06 2006-07-04 Pyrazolo [3 , 4-d] azepine derivatives as histamine h3 antagonists

Publications (2)

Publication Number Publication Date
CN101258154A CN101258154A (zh) 2008-09-03
CN101258154B true CN101258154B (zh) 2011-01-19

Family

ID=34856781

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2006800322776A Expired - Fee Related CN101258154B (zh) 2005-07-06 2006-07-04 作为组胺h3拮抗剂的吡唑并[3,4-d]氮杂䓬衍生物

Country Status (27)

Country Link
US (1) US7888347B2 (enExample)
EP (1) EP1899350B1 (enExample)
JP (1) JP5145218B2 (enExample)
KR (1) KR20080037651A (enExample)
CN (1) CN101258154B (enExample)
AT (1) ATE467636T1 (enExample)
AU (1) AU2006286897A1 (enExample)
BR (1) BRPI0612719A2 (enExample)
CA (1) CA2614232A1 (enExample)
CR (1) CR9622A (enExample)
CY (1) CY1110711T1 (enExample)
DE (1) DE602006014273D1 (enExample)
DK (1) DK1899350T3 (enExample)
EA (1) EA013600B1 (enExample)
ES (1) ES2345841T3 (enExample)
GB (1) GB0513886D0 (enExample)
HR (1) HRP20100401T1 (enExample)
IL (1) IL188184A0 (enExample)
MA (1) MA29623B1 (enExample)
MX (1) MX2008000383A (enExample)
NO (1) NO20080563L (enExample)
PL (1) PL1899350T3 (enExample)
PT (1) PT1899350E (enExample)
SI (1) SI1899350T1 (enExample)
UA (1) UA93047C2 (enExample)
WO (1) WO2007025596A1 (enExample)
ZA (1) ZA200710798B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2655604C (en) 2006-06-23 2016-08-09 Abbott Laboratories Cyclopropyl amine derivatives
US9108948B2 (en) 2006-06-23 2015-08-18 Abbvie Inc. Cyclopropyl amine derivatives
CN101868457B (zh) 2007-09-24 2013-02-13 科门蒂斯公司 作为β-分泌酶抑制剂用于治疗的(3-羟基-4-氨基-丁-2-基)-3-(2-噻唑-2-基-吡咯烷-1-羰基)苯甲酰胺衍生物和相关化合物
US9186353B2 (en) 2009-04-27 2015-11-17 Abbvie Inc. Treatment of osteoarthritis pain
US8853390B2 (en) 2010-09-16 2014-10-07 Abbvie Inc. Processes for preparing 1,2-substituted cyclopropyl derivatives
CN102952139B (zh) * 2011-08-30 2016-08-10 上海药明康德新药开发有限公司 反式-3a-氟吡咯烷[3,4-C]并环化合物及其制备方法
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
EP2647377A1 (en) 2012-04-06 2013-10-09 Sanofi Use of an h3 receptor antagonist for the treatment of alzheimer's disease
JO3407B1 (ar) 2012-05-31 2019-10-20 Eisai R&D Man Co Ltd مركبات رباعي هيدرو بيرازولو بيريميدين
US9910887B2 (en) * 2013-04-25 2018-03-06 Facebook, Inc. Variable search query vertical access
JP2019520335A (ja) * 2016-05-25 2019-07-18 アカーナ・セラピューティクス・リミテッドＡｋａｒｎａ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｌｔｄ． 疾患治療用の縮合二環式化合物

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1325267A (zh) * 1998-09-09 2001-12-05 石原产业株式会社 用作除草剂的稠合的苯衍生物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1173438A1 (en) * 1999-04-16 2002-01-23 Novo Nordisk A/S Substituted imidazoles, their preparation and use
JP2001220390A (ja) 2000-02-09 2001-08-14 Yamanouchi Pharmaceut Co Ltd 縮合ピラゾール誘導体
AU2003229535A1 (en) * 2002-06-06 2003-12-22 Novo Nordisk A/S Substituted hexahydropyrrolo(1,2-a)pyrazines, octahydropyrido(1,2-a)pyrazines and decahydropyrazino(1,2-a)azepines
US6770597B2 (en) 2002-07-17 2004-08-03 Ishihara Sangyo Kaisha, Ltd. Benzohydrazide derivatives as herbicides and desiccant compositions containing them
MXPA05000945A (es) 2002-07-25 2005-05-16 Pharmacia Italia Spa Biciclo-pirazoles activos como inhibidores de la cinasa, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
AU2003256793A1 (en) * 2002-08-20 2004-03-11 Eli Lilly And Company Substituted azepines as histamine h3 receptor antagonists, preparation and therapeutic uses
GB0224083D0 (en) 2002-10-16 2002-11-27 Glaxo Group Ltd Novel compounds
GB0224557D0 (en) 2002-10-22 2002-11-27 Glaxo Group Ltd Novel compounds
PT1572215E (pt) 2002-12-20 2009-12-09 Glaxo Group Ltd Derivados de benzo[d]azepina para o tratamento de perturbações neurológicas
SG146683A1 (en) * 2003-09-17 2008-10-30 Janssen Pharmaceutica Nv Fused heterocyclic compounds as serotonin receptor modulators
GB0329214D0 (en) 2003-12-17 2004-01-21 Glaxo Group Ltd Novel compounds
GB0405628D0 (en) 2004-03-12 2004-04-21 Glaxo Group Ltd Novel compounds
GB0408083D0 (en) 2004-04-08 2004-05-12 Glaxo Group Ltd Novel compounds
TW200611701A (en) 2004-06-18 2006-04-16 Glaxo Group Ltd Novel compounds
GB0418267D0 (en) 2004-08-16 2004-09-15 Glaxo Group Ltd Novel compounds
BRPI0518841A2 (pt) 2004-12-07 2008-12-09 Glaxo Group Ltd derivados de indenila e uso destes para o tratamento de transtornos neurolàgicos
KR20070113225A (ko) 2005-03-14 2007-11-28 글락소 그룹 리미티드 히스타민 ｈ３ 수용체에 대해 친화성을 갖는 융합된 티아졸유도체

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1325267A (zh) * 1998-09-09 2001-12-05 石原产业株式会社 用作除草剂的稠合的苯衍生物

Also Published As

Publication number Publication date
CN101258154A (zh) 2008-09-03
HRP20100401T1 (hr) 2010-09-30
EP1899350B1 (en) 2010-05-12
WO2007025596A1 (en) 2007-03-08
CR9622A (es) 2008-04-10
BRPI0612719A2 (pt) 2010-11-30
EA200800264A1 (ru) 2008-06-30
UA93047C2 (ru) 2011-01-10
JP2009500366A (ja) 2009-01-08
MX2008000383A (es) 2008-03-07
AU2006286897A1 (en) 2007-03-08
PT1899350E (pt) 2010-07-21
NO20080563L (no) 2008-02-01
MA29623B1 (fr) 2008-07-01
ATE467636T1 (de) 2010-05-15
SI1899350T1 (sl) 2010-09-30
PL1899350T3 (pl) 2010-10-29
KR20080037651A (ko) 2008-04-30
EA013600B1 (ru) 2010-06-30
ES2345841T3 (es) 2010-10-04
EP1899350A1 (en) 2008-03-19
DE602006014273D1 (de) 2010-06-24
DK1899350T3 (da) 2010-09-06
IL188184A0 (en) 2008-03-20
ZA200710798B (en) 2008-11-26
GB0513886D0 (en) 2005-08-10
JP5145218B2 (ja) 2013-02-13
US20080176832A1 (en) 2008-07-24
US7888347B2 (en) 2011-02-15
CA2614232A1 (en) 2007-03-08
CY1110711T1 (el) 2015-06-10

Similar Documents

Publication Publication Date Title
AU2019320945C1 (en) Fused ring compounds
JP6482629B2 (ja) Ｔｒｋａキナーゼ阻害剤としてのｎ−ピロリジニル、ｎ’−ピラゾリル尿素、チオ尿素、グアニジン、およびシアノグアニジン化合物
CN107253963B (zh) 吡啶酮和氮杂吡啶酮化合物及使用方法
TWI753892B (zh) 作為ｔａｍ抑制劑之吡咯并三嗪化合物
CN104341388B (zh) 芳香族酰胺类衍生物、其制备方法及其在医药上的应用
CN103288833B (zh) 作为激酶抑制剂的咪唑并三嗪和咪唑并嘧啶
AU2012323085B2 (en) PDE9i with imidazo pyrazinone backbone
JP5969054B2 (ja) Ｓｍａｃミメチックスとしての６−アルキニルピリジン
CN112105419A (zh) 稠环化合物
JP6424224B2 (ja) 新規ビスアミドピリジン
CN108290863A (zh) 可用作人壳多糖酶抑制剂的经取代的氨基三唑
CN104470924A (zh) 作为tnf活性调节剂的咪唑并吡嗪衍生物
CN102317282A (zh) 杂环衍生物
CN107108561A (zh) 用作irak抑制剂的杂芳基化合物及其用途
CN107635986A (zh) 取代的喹喔啉衍生物
JP6338665B2 (ja) 新規６−アルキニルピリジン
CN106831789A (zh) 布鲁顿酪氨酸激酶抑制剂
AU2005204060A1 (en) 2-(amino-substituted)-4-aryl pyramidines and related compounds useful for treating inflammatory diseases
WO2019062657A1 (zh) 氮杂环类衍生物、其制备方法及其医药用途
CN112313220B (zh) Pd-l1拮抗剂化合物
EP1899350B1 (en) Pyrazolo [3 , 4-d]azepine derivatives as histamine h3 antagonists
TWI597271B (zh) 三嗪酮化合物及ｔ型鈣通道抑制劑
CN107753486A (zh) 含1,6‑二取代吲哚化合物的低抗药性低副作用慢性骨髓性白血病治疗剂
WO2025140364A1 (zh) 一种稠合嘧啶环化合物、药物组合物及其应用
WO2025162210A1 (zh) 一种具备降解酪氨酸蛋白激酶btk活性的化合物及其制备方法和用途

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110119

Termination date: 20130704